课题基金 / 基金详情

Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit

Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit
用于早期癌症评估的液体活检的竞争前合作:数据管理和协调单位
批准号:
10838127
负责人:
Wei Sun
金额:
$79.2万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-22 至 2028-08-31
关键词:
AddressAdoptionAreaArtificial IntelligenceBenignBioinformaticsBiological AssayBiological MarkersBiometryBiopsyBloodBody FluidsCancer CenterCancer DetectionCancer PatientCancerousCaringCerebrospinal FluidClinicalCollaborationsCollectionCommon Data ElementCommunicationCommunitiesCommunity OutreachComputational BiologyComputer AnalysisConfidence IntervalsDataData AnalysesData Coordinating CenterData ElementData ScienceData Storage and RetrievalDetectionDevelopmentDiseaseEarly Detection Research NetworkEducational workshopGoalsImageIndolentInformaticsLeadershipLesionMachine LearningMalignant NeoplasmsManualsMethodsMolecularMorbidity - disease rateNational Cancer InstituteNeoplasm Circulating CellsPatientsPerformancePopulationPositioning AttributeProceduresProteinsRNAReproducibilityReproducibility of ResultsResearchResearch DesignResearch MethodologyResearch PersonnelResearch SupportResourcesSalivaScienceScientific Advances and AccomplishmentsScreening for cancerSecureSensitivity and SpecificitySomatotypeSpecimenSputumStandardizationStatistical Data InterpretationStatistical MethodsSystemTechniquesTechnologyTissuesTranslational ResearchUrineValidationWorkbig data managementbiomarker developmentbiomarker validationcancer diagnosiscancer typecell free DNAcloud storagecurative treatmentsdata centersdata managementdata sharingdata standardsdeep learningdesignexosomeexperienceextracellular vesiclesfederated learningimprovedinnovationlaboratory experiencelearning strategyliquid biopsymachine learning modelmachine learning predictionmeetingsmemberminimally invasivemolecular imagingmortalitymultidisciplinarynotch proteinnoveloperationoutreachpre-clinicalpremalignantprogramsprospectiveprotocol developmentresearch clinical testingresponseservice coordinationstatisticssymposiumtumortumor DNAvalidation studiesweb site

项目摘要

项目成果

Wei Sun的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Liquid biopsy is a clinical test that involves the analysis of various biomarkers present in the blood or other types of body fluids. It enables the detection of cancer at an earlier stage than traditional imaging or tissue biopsy methods, and thus can lead to reduction of cancer mobility and mortality. As one of the most promising solutions for cancer early detection, liquid biopsy has the potential to revolutionize cancer diagnosis, providing patients with more effective and less invasive care. The liquid biopsy analytes include circulating tumor cells (CTCs), circulating tumor DNA, which is part of cell-free DNA (cfDNA), extracellular vesicles, as well other tumor associated RNAs, proteins and metabolites. These analytes typically have very low levels in blood or other types of body fluid of early-stage cancer patients, leading to difficulties in obtaining reproducible results and low sensitivity and specificity for cancer early detection. While many new assays and techniques have been developed to tackle these challenges, validation of these assays/techniques in different populations and/or cancer types poses many challenges, and these are the main areas of research supported by the liquid biopsy consortium (LBC). As Data Management and Coordinating Unit (DMCU) of LBC, we will support state- of-the-art statistical methods for study design and data analysis, the coordination, implementation, and conduct of collaborative studies across the consortium and work closely with LBC investigators on data analysis by statistical methods, machine Learning modeling and Artificial Intelligence. We will also support consortium coordination and data management, including identification and adoption of standard data elements for liquid biopsy studies. We seek to establish the DMCU as a leading center for innovation and resources in liquid biopsy research, and to enhance, improve and maintain LBC network integration and coordination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Post-GWAS Functional Genomics Analysis to Define Pathogenic Mechanisms for Pulmonary Arterial Hypertension
Yersinia Outer-Membrane-Vesicle Vaccines Against Pneumonic Plague
  • 批准号:
    10673295
  • 项目类别:
  • 资助金额:
    $25.41万
  • 财政年份:
    2022
  • 负责人:
    Wei Sun
  • 依托单位:
Yersinia Outer-Membrane-Vesicle Vaccines Against Pneumonic Plague
  • 批准号:
    10555332
  • 项目类别:
  • 资助金额:
    $70.69万
  • 财政年份:
    2022
  • 负责人:
    Wei Sun
  • 依托单位:
Yersinia Outer-Membrane-Vesicle Vaccines Against Pneumonic Plague
  • 批准号:
    10441853
  • 项目类别:
  • 资助金额:
    $58.46万
  • 财政年份:
    2022
  • 负责人:
    Wei Sun
  • 依托单位:
海外基金